Nominal 
[ET Net News Agency, 7 July 2026] CH BIOTECH SER (08037) rose 40.9% to HK$0.62.
It hits an intra-day high of HK$0.63, hitting an 1-month high, breaking above the 50-D SMA of HK$0.574, and an intra-day low of HK$0.44. The total shares traded was 760,000, with a value of HK$425,525. The active buy/sell ratio is 71:29, with net buying turnover of HK$169,025. FUTU SEC INT'L accounts for greatest net responsive buying turnover of HK$52,825, with volume weighted average price of HK$0.538. CITIC SEC BRO accounts for greatest net responsive selling turnover of HK$44,475, with volume weighted average price of HK$0.523. The stock has risen a combined 45.9% over the past 2 consecutive trading days.
Status: Breaking above the 50-D SMA, hitting an 1-month high, active buy/sell ratio is 71:29, with net buying turnover of HK$169,025, rising a combined 45.9% over the past 2 consecutive trading days
(ed)
It hits an intra-day high of HK$0.63, hitting an 1-month high, breaking above the 50-D SMA of HK$0.574, and an intra-day low of HK$0.44. The total shares traded was 760,000, with a value of HK$425,525. The active buy/sell ratio is 71:29, with net buying turnover of HK$169,025. FUTU SEC INT'L accounts for greatest net responsive buying turnover of HK$52,825, with volume weighted average price of HK$0.538. CITIC SEC BRO accounts for greatest net responsive selling turnover of HK$44,475, with volume weighted average price of HK$0.523. The stock has risen a combined 45.9% over the past 2 consecutive trading days.
| Nominal | 0.620 | % Chg | +40.91% |
| High | 0.630 | Low | 0.440 |
| Shares Tr | 760,000 | Turnover | 425,525 |
| 10-D SMA | 0.494 | %H.V | 110.538 |
| 20-D SMA | 0.498 | VWAP | 0.560 |
| 50-D SMA | 0.574 | RSI14 | 62.803 |
(ed)